Hepatic phase I and phase II biotransformations in quail and trout: Comparison to other species commonly used in toxicity testing

Zoltan Gregus, John B. Watkins, Thomas N. Thompson, Michael J. Harvey, Karl Rozman, Curtis D. Klaassen

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

The ability of quail and trout to perform a number of representative phase I and phase II biotransformations was examined. To facilitate interspecies comparisons, metabolism of the same substrates was examined simultaneously under uniform conditions for rat, mouse, rabbit, guinea pig, cat, and dog. Both nonmammalian species can metabolize four representative substrates of phase I mixed-function oxidases and one substrate of epoxide hydrolase, though activity tended to be lower than that of the mammals. Important differences in the conjugative pathways were also noted. Among these differences were the quail's relative deficiency in glutathione conjugation and the trout's low ability to conjugate sulfate compounds. Trout liver UDP-glucuronosyltransferase activity was remarkably high toward testosterone and bilirubin, while quail liver formed glucuronides of naphthol, p-nitrophenol, and digitoxigenin-monodigitoxoside. Also noteworthy was the high N-acetyltransferase activity of both quail and trout toward isoniazid, β-naphthylamine, and 2-aminofluorene. Differences in substrate specificity for a given enzymatic pathway may be an indication that multiple forms of drug metabolizing systems also occur in these nonmammalian species. Observation of several hundred- or even thousand-fold differences between species in their enzyme activities for certain substrates under uniform conditions reemphasizes the need for caution in extrapolation of xenobiotic metabolism from one species to another.

Original languageEnglish (US)
Pages (from-to)430-441
Number of pages12
JournalToxicology and Applied Pharmacology
Volume67
Issue number3
DOIs
StatePublished - Mar 15 1983
Externally publishedYes

Fingerprint

Quail
Trout
Biotransformation
Toxicity
Liver
Testing
Substrates
Metabolism
Epoxide Hydrolases
Naphthols
Glucuronosyltransferase
Acetyltransferases
Isoniazid
Xenobiotics
Substrate Specificity
Mixed Function Oxygenases
Bilirubin
Mammals
Sulfates
Glutathione

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Hepatic phase I and phase II biotransformations in quail and trout : Comparison to other species commonly used in toxicity testing. / Gregus, Zoltan; Watkins, John B.; Thompson, Thomas N.; Harvey, Michael J.; Rozman, Karl; Klaassen, Curtis D.

In: Toxicology and Applied Pharmacology, Vol. 67, No. 3, 15.03.1983, p. 430-441.

Research output: Contribution to journalArticle

Gregus, Zoltan ; Watkins, John B. ; Thompson, Thomas N. ; Harvey, Michael J. ; Rozman, Karl ; Klaassen, Curtis D. / Hepatic phase I and phase II biotransformations in quail and trout : Comparison to other species commonly used in toxicity testing. In: Toxicology and Applied Pharmacology. 1983 ; Vol. 67, No. 3. pp. 430-441.
@article{6e576e33d6ee4a1bbe1a139c8a6300ce,
title = "Hepatic phase I and phase II biotransformations in quail and trout: Comparison to other species commonly used in toxicity testing",
abstract = "The ability of quail and trout to perform a number of representative phase I and phase II biotransformations was examined. To facilitate interspecies comparisons, metabolism of the same substrates was examined simultaneously under uniform conditions for rat, mouse, rabbit, guinea pig, cat, and dog. Both nonmammalian species can metabolize four representative substrates of phase I mixed-function oxidases and one substrate of epoxide hydrolase, though activity tended to be lower than that of the mammals. Important differences in the conjugative pathways were also noted. Among these differences were the quail's relative deficiency in glutathione conjugation and the trout's low ability to conjugate sulfate compounds. Trout liver UDP-glucuronosyltransferase activity was remarkably high toward testosterone and bilirubin, while quail liver formed glucuronides of naphthol, p-nitrophenol, and digitoxigenin-monodigitoxoside. Also noteworthy was the high N-acetyltransferase activity of both quail and trout toward isoniazid, β-naphthylamine, and 2-aminofluorene. Differences in substrate specificity for a given enzymatic pathway may be an indication that multiple forms of drug metabolizing systems also occur in these nonmammalian species. Observation of several hundred- or even thousand-fold differences between species in their enzyme activities for certain substrates under uniform conditions reemphasizes the need for caution in extrapolation of xenobiotic metabolism from one species to another.",
author = "Zoltan Gregus and Watkins, {John B.} and Thompson, {Thomas N.} and Harvey, {Michael J.} and Karl Rozman and Klaassen, {Curtis D.}",
year = "1983",
month = "3",
day = "15",
doi = "10.1016/0041-008X(83)90327-7",
language = "English (US)",
volume = "67",
pages = "430--441",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Hepatic phase I and phase II biotransformations in quail and trout

T2 - Comparison to other species commonly used in toxicity testing

AU - Gregus, Zoltan

AU - Watkins, John B.

AU - Thompson, Thomas N.

AU - Harvey, Michael J.

AU - Rozman, Karl

AU - Klaassen, Curtis D.

PY - 1983/3/15

Y1 - 1983/3/15

N2 - The ability of quail and trout to perform a number of representative phase I and phase II biotransformations was examined. To facilitate interspecies comparisons, metabolism of the same substrates was examined simultaneously under uniform conditions for rat, mouse, rabbit, guinea pig, cat, and dog. Both nonmammalian species can metabolize four representative substrates of phase I mixed-function oxidases and one substrate of epoxide hydrolase, though activity tended to be lower than that of the mammals. Important differences in the conjugative pathways were also noted. Among these differences were the quail's relative deficiency in glutathione conjugation and the trout's low ability to conjugate sulfate compounds. Trout liver UDP-glucuronosyltransferase activity was remarkably high toward testosterone and bilirubin, while quail liver formed glucuronides of naphthol, p-nitrophenol, and digitoxigenin-monodigitoxoside. Also noteworthy was the high N-acetyltransferase activity of both quail and trout toward isoniazid, β-naphthylamine, and 2-aminofluorene. Differences in substrate specificity for a given enzymatic pathway may be an indication that multiple forms of drug metabolizing systems also occur in these nonmammalian species. Observation of several hundred- or even thousand-fold differences between species in their enzyme activities for certain substrates under uniform conditions reemphasizes the need for caution in extrapolation of xenobiotic metabolism from one species to another.

AB - The ability of quail and trout to perform a number of representative phase I and phase II biotransformations was examined. To facilitate interspecies comparisons, metabolism of the same substrates was examined simultaneously under uniform conditions for rat, mouse, rabbit, guinea pig, cat, and dog. Both nonmammalian species can metabolize four representative substrates of phase I mixed-function oxidases and one substrate of epoxide hydrolase, though activity tended to be lower than that of the mammals. Important differences in the conjugative pathways were also noted. Among these differences were the quail's relative deficiency in glutathione conjugation and the trout's low ability to conjugate sulfate compounds. Trout liver UDP-glucuronosyltransferase activity was remarkably high toward testosterone and bilirubin, while quail liver formed glucuronides of naphthol, p-nitrophenol, and digitoxigenin-monodigitoxoside. Also noteworthy was the high N-acetyltransferase activity of both quail and trout toward isoniazid, β-naphthylamine, and 2-aminofluorene. Differences in substrate specificity for a given enzymatic pathway may be an indication that multiple forms of drug metabolizing systems also occur in these nonmammalian species. Observation of several hundred- or even thousand-fold differences between species in their enzyme activities for certain substrates under uniform conditions reemphasizes the need for caution in extrapolation of xenobiotic metabolism from one species to another.

UR - http://www.scopus.com/inward/record.url?scp=0020628853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020628853&partnerID=8YFLogxK

U2 - 10.1016/0041-008X(83)90327-7

DO - 10.1016/0041-008X(83)90327-7

M3 - Article

C2 - 6845369

AN - SCOPUS:0020628853

VL - 67

SP - 430

EP - 441

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 3

ER -